The TrumpRx.gov website helps uninsured & cash-paying patients save on 40+ brand drugs. Here's the complete list of ...
Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approval SEATTLE, Feb. 5, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc.
The UIW's Feik School of Pharmacy achieved the highest pharmacy licensure exam pass rate in Texas, while the Class of 2025 ...
Pharmacy leaders should watch Medicare MFP as it changes Part D drug pricing and introduces new reconciliation challenges for ...
Total net revenue of $15.2 million Adjusted EBITDA1 of $ (0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) ...
NMD Pharma is accelerating ignaseclant’s clinical development in CMT alongside multiple near-term clinical catalysts across its neuromuscular pipeline, with Phase 2 studies in spinal muscular atrophy ...
Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...
Solutions exist to control the rising costs of pharmaceuticals in employee-funded health insurance plans, but long-entrenched ...
Union Finance Minister Nirmala Sitharaman presented the Economic Survey 2026 in Lok Sabha on Thursday, January 29, ahead of ...
FirstWord Pharma’s 2026 list aggregates core pipeline assets from the world’s leading pharmaceutical companies. Alongside ivonescimab, the list highlights transformative therapies such as Eli Lilly’s ...
The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...
The "Data Integrity Auditor Masterclass Training Course (Apr 22nd - Apr 23rd, 2026)" training has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results